MASSACHUSETTS FINANCIAL SERVICES CO /MA/ - COLLEGIUM PHARMACEUTICAL INC ownership

COLLEGIUM PHARMACEUTICAL INC's ticker is COLL and the CUSIP is 19459J104. A total of 122 filers reported holding COLLEGIUM PHARMACEUTICAL INC in Q4 2018. The put-call ratio across all filers is 0.33 and the average weighting 0.2%.

Quarter-by-quarter ownership
MASSACHUSETTS FINANCIAL SERVICES CO /MA/ ownership history of COLLEGIUM PHARMACEUTICAL INC
ValueSharesWeighting
Q3 2023$14,852,000
+4.2%
664,519
+0.2%
0.01%0.0%
Q2 2023$14,256,101
-11.2%
663,383
-0.9%
0.01%0.0%
Q1 2023$16,060,993
-15.5%
669,487
-18.3%
0.01%
-28.6%
Q4 2022$19,014,998
+45.3%
819,612
+0.3%
0.01%
+40.0%
Q3 2022$13,087,000
-15.1%
816,926
-6.1%
0.01%0.0%
Q2 2022$15,422,000
-12.4%
870,306
+0.6%
0.01%0.0%
Q1 2022$17,607,000
+11.9%
864,782
+2.7%
0.01%
+25.0%
Q4 2021$15,736,000
-3.0%
842,381
+2.5%
0.00%
-20.0%
Q3 2021$16,221,000
-17.6%
821,747
-1.3%
0.01%
-16.7%
Q2 2021$19,682,000
+29.1%
832,554
+29.4%
0.01%
+20.0%
Q1 2021$15,247,000
+15.4%
643,322
-2.5%
0.01%
+25.0%
Q4 2020$13,215,000
-2.3%
659,739
+1.5%
0.00%
-20.0%
Q3 2020$13,529,000
+15.9%
649,799
-2.6%
0.01%0.0%
Q2 2020$11,671,000
+47.8%
666,918
+37.9%
0.01%
+25.0%
Q1 2020$7,897,000
-22.3%
483,566
-2.1%
0.00%0.0%
Q4 2019$10,169,000
+50.6%
494,138
-16.0%
0.00%
+33.3%
Q3 2019$6,752,000
-13.0%
588,145
-0.4%
0.00%0.0%
Q2 2019$7,764,000
-12.6%
590,392
+0.6%
0.00%
-25.0%
Q1 2019$8,886,000
-22.0%
586,942
-11.5%
0.00%
-20.0%
Q4 2018$11,392,000
+19.0%
663,498
+2.1%
0.01%
+25.0%
Q3 2018$9,575,000
-4.3%
649,624
+54.8%
0.00%0.0%
Q2 2018$10,009,000
-5.3%
419,656
+1.4%
0.00%
-20.0%
Q1 2018$10,574,000
+27.5%
413,838
-7.9%
0.01%
+66.7%
Q4 2017$8,293,000
+17.5%
449,265
-33.2%
0.00%0.0%
Q3 2017$7,056,000
-15.6%
672,627
+0.6%
0.00%
-25.0%
Q2 2017$8,364,000
+29.9%
668,558
+4.4%
0.00%
+33.3%
Q1 2017$6,440,000
-7.9%
640,189
+42.5%
0.00%0.0%
Q4 2016$6,993,000
-28.7%
449,127
-11.8%
0.00%
-40.0%
Q3 2016$9,803,000
+65.3%
508,995
+1.7%
0.01%
+66.7%
Q2 2016$5,929,000
-9.8%
500,309
+38.2%
0.00%0.0%
Q1 2016$6,570,000
-33.2%
362,004
+1.2%
0.00%
-40.0%
Q4 2015$9,833,000
+23.5%
357,584
-0.7%
0.01%
+25.0%
Q3 2015$7,959,000
-99.9%
359,966
-26.3%
0.00%0.0%
Q2 2015$8,715,019,000488,5100.00%
Other shareholders
COLLEGIUM PHARMACEUTICAL INC shareholders Q4 2018
NameSharesValueWeighting ↓
Tejara Capital Ltd 289,803$6,477,0973.67%
Tamarack Advisers, LP 185,000$4,134,7502.68%
Rubric Capital Management LP 3,175,000$70,961,2502.66%
Eventide Asset Management 2,631,334$58,810,3151.06%
Camber Capital Management LP 1,050,000$23,4680.77%
EMERALD MUTUAL FUND ADVISERS TRUST 559,480$12,504,3780.76%
EMERALD ADVISERS, LLC 690,487$15,432,3800.75%
Values First Advisors, Inc. 43,507$972,3740.63%
AlphaCentric Advisors LLC 49,500$1,106,3250.63%
SummerHaven Investment Management, LLC 33,666$752,4350.55%
View complete list of COLLEGIUM PHARMACEUTICAL INC shareholders